Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group - Concepedia

Concepedia

Publication | Closed Access

Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group

69

Citations

0

References

1993

Year

H. Döhner, Anthony D. Ho, J. Thaler, Pierre Stryckmans, Pieter Sonneveld, Theodore Witte, Klaus Lechner, F. Lauria, S. Bödewadt-Radzun, Stefan Suciu,

JNCI Journal of the National Cancer Institute

Abstract

Trials using DCF or other purine analogues alone or in combination with standard chemotherapeutic agents in front-line or salvage therapy are warranted to improve the prognosis of patients with prolymphocytic leukemia.